Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 6 , Pages 714-729 , December 2010

Advances in polymeric micelles for drug delivery and tumor targeting

  • Uttam Kedar, MPharm

      Affiliations

    • Bharati Vidyapeeth's College of Pharmacy, Mumbai, India
    • ,
  • Prasanna Phutane, MPharm

      Affiliations

    • Bharati Vidyapeeth's College of Pharmacy, Mumbai, India
    • Corresponding Author InformationCorresponding author: Bharati Vidyapeeth's College of Pharmacy, CBD Belapur, Navi Mumbai 400 614, India.
    • ,
  • Supriya Shidhaye, MPharm, PhD, Tech

      Affiliations

    • Vivekanand Education Society's College of Pharmacy, Mumbai, India
    • ,
  • Vilasrao Kadam, MPharm, PhD

      Affiliations

    • Bharati Vidyapeeth's College of Pharmacy, Mumbai, India

Received 5 November 2009 ,Accepted 18 May 2010.

References 

  1. Yokoyama M. Polymeric micelles drug carriers for tumor targeting. In:  Svenson S editors. Polymeric drug delivery. Particulate drug carriers, Series 924. Vol. 1:Washington, DC: ACS Publications; 2006;p. 27–36
  2. Wang L, Zeng R, Li C, Qiao R. Self-assembled polypeptide-block-poly(vinylpyrrolidone) as prospective drug-delivery systems. Colloids Surfaces B. 2009;74:284–292
  3. Yokoyama M, Kwon GS, Okano T, Sakurai Y, Seto TK, Kataoka K. Preparation of micelle-forming polymer-drug conjugates. Bioconjug Chem. 1992;3:295–301
  4. Weissig V, Whiteman KR, Torchilin VP. Immunomicelles targeted pharmaceutical carriers for poorly soluble drugs. Pharm Res. 1998;15:1552–1556
  5. Liu R, Forrest ML, Kwon GS. Water insoluble drug formulation. In:  Rong Liu editors. Micellization and drug solubility enhancement. Part II: Polymeric micelles. 2nd ed.. Boca Raton, FL: CRC Press; 2007;p. 334
  6. Matsumura Y. Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles. J Drug Target. 2007;15:507–517
  7. Yokoyama M, Okano T, Sakurai Y, Suwa S, Kataoka K. Introduction of cisplatin into polymeric micelles. J Control Release. 1996;39:351–356
  8. Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, et al. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 1990;50:1693–1700
  9. Kataoka K, Togawa H, Harada A, Yasugi K, Matsumoto T, Katayose S. Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules. 1996;29:8556–8557
  10. Harada A, Kataoka K. Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments. Macromolecules. 1995;28:5294–5299
  11. Bronich TK, Kabanov VA, Kabanov AV, Eisenberg A. Soluble complexes from poly(ethylene oxide)-block-polymethacrylate anions and N-Alkylpyridinium cations. Macromolecules. 1997;30:3519–3525
  12. Chen W, Chen HR, Hu JH, Yang WL, Wang CC. Synthesis and characterization of polyion complex micelles between poly(ethylene glycol)-grafted poly(aspartic acid) and cetyltrimethyl ammonium bromide. Colloids and Surfaces A: Physicochem Eng Asp. 2006;278:60–66
  13. Torchilin VP. Structure and design of polymeric surfactant based drug delivery systems. J Control Release. 2001;73:137–172
  14. Shen Y, Jiasheng T. Synthesis and characterization of low molecular weight hyaluronic acid-based cationic micelles for efficient siRNA delivery. Carbohydrate Polym. 2009;77:95–104
  15. Rijcken CJ, Snel CJ, Schiffelers RM, Van Nostrum CF, Hennink WE. Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. Biomaterials. 2007;28:5581–5593
  16. Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther. 2006;112:630–648
  17. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev. 2003;55:403–419
  18. Van Hasselt PM, Janssens GEPJ, Slot TK, van der Ham M, Minderhoud TC, Talelli M, et al. The influence of bile acids on the oral bioavailability of vitamin K encapsulated in polymeric micelles. J Control Release. 2009;133:161–168
  19. Bromberg L. Polymeric micelles in oral chemotherapy. J Control Release. 2008;128:99–112
  20. Gref R, Minamitake Y, Percocchia MT, Trubetskoy V, Torchillin VP, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263:1600–1603
  21. Shuai X, Merdan T, Schaper AK, Xi F, Kissel T. Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjug Chem. 2004;154:441–448
  22. Fernandez AM, Van DK, Dasnois L, Lebtahi K, Dubois V, Lobl TJ, et al. N-succinyl-(β-alanyl-l-leucyl-l-alanyl-l-leucyl) doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity. J Med Chem. 2001;44:3750–3753
  23. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3–26
  24. Savic R, Eisenberg A, Maysinger D. Block copolymer micelles as delivery vehicles of hydrophobic drugs: micelle-cell interactions. J Drug Target. 2006;14:343–355
  25. Hageluken A, Grunbaum L, Numberg B, Harhammer R, Schunark W, Scifert R. Lipophilic beta-adrenoceptor antagonist and local anaesthetics are effective direct activators of G-proteins. Biochem Pharmacol. 1994;47:1789–1795
  26. Lipinski CA. Drug like properties and causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods. 2000;44:235–249
  27. Senior JH. Fate and behaviour of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst. 1987;3:123–193
  28. Zhang Z, Grijpma DW, Feijen J. Thermo-sensitive transition of monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) films to micellar-like nanoparticles. J Control Release. 2006;112:57–63
  29. Torchilin VP, Trubetskoy VS, Whiteman KR, Caliceti P, Ferruti P, Veronese FM. New synthetic amphiphilic polymers for steric protection of liposomes in vivo. J Pharm Sci. 1995;84:1049–1053
  30. Stepanek M, Podhajecka K, Tesarova E, Prochazka K. Hybrid polymeric micelles with hydrophobic cores and mixed polyelectrolyte/nonelectrolyte shells in aqueous media. I. Preparation and basic characterization. Langmuir. 2001;17:4240–4244
  31. Li Y, Kwon GS. Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-l-aspartamide). I. Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm Res. 2000;17:607–611
  32. Kozlov MY, Melik-Nubarov NS, Batrakova EV, Kabanov AV. Relationship between Pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes. Macromolecules. 2000;33:3305–3313
  33. Alakhov VY, Moskaleva EY, Batrakova EV, Kabanov AV. Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 copolymer. Bioconjug Chem. 1996;7:209–216duplicated later
  34. Batrakova EV, Vinogradov SV, Alkhov VY, Miller DW, Kabanov AV. Mechanism of Pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther. 2001;299:483–492
  35. Batrakova EV, Li S, Alakhov VYu, Kabanov AV. Selective energy depletion and sensitization of multiple drug resistant cancer cells by Pluronic block copolymers. Polymer Prep. 2000;41:1639–1640
  36. Hrycyna CA, Ramachandra M, Ambudkar SV, Ko YH, Pedersen PL. Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites. J Biol Chem. 1998;273:16631–16634
  37. Klok HA, Vandermeulen M, Guido W, Rosler A. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Del Rev. 2001;53:95–108
  38. Lavasanifar A, Samuel J, Kwon GS. The effect of alkyl core structure on micellar properties of poly(ethylene oxide)-block-poly(l-aspartamide) derivatives. Colloids Surfaces B Biointerfaces. 2001;22:115–126
  39. O'Reilly RK, Hawker CJ, Wooley KL. Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. Chem Soc Rev. 2006;35:1068–1083
  40. Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Physical entrapment of adriamycin in AB block copolymer micelles. Pharm Res. 1995;12:195–204
  41. Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci. 2003;92:1343–1355duplicated later
  42. Lin J, Zhu J, Chen T, Lin S, Cai C, Zhang L, et al. Drug releasing behaviour of hybrid micelles containing polypeptide triblock copolymer. Biomaterials. 2009;30:108–117
  43. Lee ES, Na K, Bae YH. Polymeric micelles for tumor pH and folate mediated targeting. J Control Release. 2003;91:103–1133 duplicates below
  44. Gao ZG, Lee DH, Kim DL, Bae LH. Doxorubicin loaded pH-sensitive micelles targeting acidic extracellular pH of human ovarian A2780 tumor in mice. J Drug Target. 2005;13:391–397duplicated later
  45. Lee ES, Na K, Bae YH, Shin HJ. Poly(l-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release. 2003;90:363–374
  46. Leroux J, Roux E, Garrec D, Hang IC, Drummond DC. N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J Control Release. 2001;72:71–84duplicated later
  47. Lin J, Lin S, Zhu J, Chen T, Cai C, Wang XS, et al. Drug releasing behaviour of hybrid micelles containing polypeptide triblock copolymer. Biomaterials. 2009;30:108–117
  48. Yang M, Ding Y, Zhang L, Qian X, Jiang X, Liu B. Novel thermosensitive polymeric micelles for docetaxel delivery. J Biomed Mater Res. 2007;81A:847–857
  49. Chung JE, Yokoyama M, Okano T, Yamato M, Aoyagi T, Sakurai Y. Thermoresponsive drug delivery from polymeric micelles constructed using block copolymer of poly(N-isopropylacrylamide) and poly(butyl methacrylate). J Control Release. 1999;62:115–127
  50. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptors. Adv Drug Deliv Rev. 2000;41:147–162
  51. Lavasanifar A, Samuel J, Kwon GS. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate l-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. J Control Release. 2001;77:155–160
  52. Kim JH, Emoto K, Iijima M, Nagasaki Y, Aoyagi T, Okano TY, et al. Core-stabilized polymeric micelle as potential drug carrier: increased solubilization of taxol. Polym Adv Technol. 1999;10:647–654
  53. Zhiang J, Wu M, Yang J, Wu Q, Jin Z. Anionic poly (lactic acid)-polyurethane micelles as potential biodegradable drug delivery carriers. Colloids Surfaces A. 2009;337:200–204
  54. Patil YB, Toti US, Khdair A, Linan M, Panyam J. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials. 2009;30:859–866
  55. Elliott RL, Elliott MC, Wang F, Head JF. Breast carcinoma and the role of iron metabolism: a cytochemical, tissue culture and ultrastructural study. Ann N Y Acad Sci. 1993;698:159–166
  56. Yokoyama M. Polymeric micelles for the targeting of hydrophobic drugs. In: Kwon GS, editor. Polymeric drug delivery systems, Vol. 148. Boca Raton (Fla): Taylor and Francis CRC Press. p. 533-560.
  57. Lee AL, Yong W, Cheng HY, Pervaiz S, Yang YY. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. Biomaterials. 2009;30:919–927
  58. Hruby M, Konak C, Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J Control Release. 2005;103:137–148
  59. La SB, Okano T, Kataoka K. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl-l-aspartate) block copolymer micelles. J Pharm Sci. 2000;85:85–90
  60. Patel S, Levasanifer A, Choi P. Application of molecular dynamics simulation to predict compatibility between water-insoluble drugs and self associating poly(ethylene oxide)-poly (ɛ-caprolactone) block copolymers. Biomacromolecules. 2008;9:3014–3023
  61. Yokoyama M, Okano T, Sakurai Y, Kataoka K. Improved synthesis of adriamycin conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Control Release. 1994;32:269–277
  62. Nah JW, Jeong YI, Cho CS. Clonazepam release from core-shell type nanoparticles composed of poly(γ-benzyl-l-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part. J Polym Sci B Polym Phys. 1998;36:415–423
  63. Wang Y, Yu L, Han L, Sha X, Fang X. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int J Pharm. 2007;337:63–73
  64. Hu FQ, Ren GF, Yuan H, Du YZ, Zeng S. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf B. 2006;50:97–103
  65. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design characterisation and biological significance. Adv Drug Deliv Rev. 2001;47:113–131
  66. Dufresne MH, Fournier E, Jones MC, Ranger M, Leroux JC. Block copolymer micelles—engineering versatile carriers for drugs and biomacromolecules. In:  Gurny R editors. Challenges in drug delivery for the new millennium. 96:Saint-Priest: Bulletin Technique Gattefosse; 2003;p. 87–102
  67. Nishiyama N, Kataoka K. Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum (II) in the core. J Control Release. 2001;74:83–94
  68. Butsele KV, Sibreta P, Fustin CA, Gohyb JF, Passirani C, Benoitc JP, et al. Synthesis and pH-dependent micellization of diblock copolymer mixtures. J Colloid Interf Sci. 2009;329:235–243
  69. Zhang J, Jiang W, Zhao X, Wang Y. Preparation and characterization of polymeric micelles from poly(d,l-lactide) and methoxypolyethylene glycol block copolymers as potential drug carriers. Tsinghua Sci Technol. 2007;12:493–496
  70. Hongyu C, Na L, Xing W, Zhen J, Zhiming C. Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC-b-PBMA copolymer. Int J Pharm. 2009;371:190–196
  71. Zhang X, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm. 1996;132:195–206
  72. Taillefer J, Jones MC, Brasseur N, Van Lier JE, Leroux JC. Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs. J Pharm Sci. 2000;89:52–62
  73. Nobuhiro N, Souichiro O, Horacio C, Masaki M, Yukio K, Yuichi S, et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 2003;63:8977–8983
  74. Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, et al. PLGA–lecithin PEG core-shell nanoparticles for controlled drug delivery. Biomaterials. 2009;30:1627–1634
  75. Der ZL, Jui HH, Xian CF, Jean DY, Tze Wen C. Synthesis, characterization and drug delivery behaviors of new PCP polymeric micelles. Carbohydrate Polym. 2007;68:544–554
  76. Bontha S, Kabanov AV, Bronich TK. Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs. J Control Release. 2006;114:163–174
  77. Thurmond KB, Huang H, Clark CG, Kowalewski T, Wooley KL. Shell crosslinked polymer micelles: stabilized assemblies with great versatility and potential. Colloids Surf B. 1999;16:45–54
  78. Buetuen V, Lowe AB, Billingham NC, Armes SP. Synthesis of zwitterionic shell crosslinked micelles. J Am Chem Soc. 1999;121:4288–4289
  79. Chung JE, Yokoyama M, Okano T. Inner core segment design for drug delivery: control of thermoresponsive polymeric micelles. J Control Release. 2000;65:93–103
  80. Sahoo SK, Labhesetwar V. Enhanced anti-proliferative activity of transferrin conjugated paclitaxel-loaded nanoparticle is mediated via sustained intracellular drug retention. Mol Pharm. 2005;2:373–383duplicated later
  81. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 1999;6:595–605
  82. Bae Y, Jang WD, Nishiyama N, Fukushima S, Kataoka K. Multifunctional polymeric micelles with folate mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol Biosyst. 2005;1:241–250duplicate
  83. Seymour LW, Duncan R, Strohalm J, Kopecek J. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal and intravenous administration to rats. J Biomed Mater Res. 1987;21:1341–1358
  84. Dodgin M, Pantigny J, Aubard J, Schwallar WA. Acid base properties of ellipticine bound to DNA, micelles and liposomes. Anticancer Drug Des. 1990;5:129–134
  85. Ashok B, Arleth L, Hjelm RP, Rubinstein I, et al. In vitro characterization of pegylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J Pharm Sci. 2004;93:2476–2487
  86. Yunhai L, Xiaohong C, Mingbiao L, Zhanggao L, Wenyuan X. Self-assembled micellar nanoparticles of a novel star copolymer for thermo and pH dual-responsive drug release. J Colloid Interf Sci. 2009;329:244–252
  87. Kwon G, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Micelles based on AB block copolymers of poly(ethylene oxide) and poly(beta-benzyl l-aspartate). Langmuir. 1993;9:945–949
  88. Wilhelm M, Zhao CL, Wang YC, Xu RL, Winnik MA, Mura JL, et al. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study. Macromolecules. 1991;24:1033–1040
  89. Bussche EV, Deene YD, Dubruel P, Vergote K, Schacht E, Wagter CD. The use of static light scattering for the structure analysis of radiosensitive polymer gels: a literature survey. J Physics Conf Ser. 2004;3:180–183
  90. Lee H, Soo PL, Liu J, Butler M, Allen C. Polymeric micelles for formulation of anticancer drugs. In:  Amiji MM editors. Nanotechnology for cancer therapy. Boca Raton (Fla): CRC Press; 2007;p. 317–355Chapter 17
  91. Prasad V, Semwogerere D, Eric RW. Confocal microscopy of colloids. J Phys Condens Matter. 2007;19:113–138
  92. Liu J, Yang S, Lee CS, DeVoe DL. Polyacrylamide gel plugs enabling 2-D microfluidic protein separations via isoelectric focusing and multiplexed sodium dodecyl sulfate gel electrophoresis. Electrophoresis. 2008;29:2241–2250
  93. Zeng Y, Pitt WG. A polymeric micelle system with a hydrolysable segment for drug delivery. J Biomater Sci Polym. 2006;17:591–604
  94. Chen Y, Sone M, Fuchise K, Sakai R, Kakuchi R, Duan Q, et al. Structural effect of a series of block copolymers consisting of poly(N-isopropylacrylamide) and poly(N-hydroxyethylacrylamide) on thermoresponsive behavior. React Funct Polym. 2009;69:463–469
  95. Cowie JMG, McKenzie J, Cowie G. In: 2nd ed. Polymers: chemistry and physics of modern materials. Cheltenham, UK: Nelson Thornes Ltd; 1991;p. 187–210
  96. Hayama A, Yamamoto T, Yokoyama M, Kawano K, Hattori Y, Maitani Y. Polymeric micelles modified by folate-PEG-lipid for targeted drug delivery to cancer cells in vitro. J Nanosci Nanotechnol. 2007;8:1–6
  97. Young IJ, Hee-Sam N, Kyoung-Oh C, Hyun CL, Jae-Woon N, Chong-Su C. Antitumor activity of adriamycin-incorporated polymeric micelles of poly(γ-benzyl-l-glutamate)/ poly(ethylene oxide). Int J Pharm. 2009;365:150–156
  98. Cho YW, Lee J, Lee SC, Huh KM, Park K. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J Control Release. 2004;97:249–257
  99. Cabral H, Nakanishi M, Kumagai M, Jang WD, Nishiyama N, Kataoka K. A photoactivated targeting chemotherapy using glutathione sensitive camptothecin-loaded polymeric micelles. Pharm Res. 2009;26:82–92
  100. Schiffelers RM, Bakker-Woudenberg IA, Snijders SV, Storm G. Localization of sterically stabilized liposomes in Klebsiella-pneumoniae-infected rat lung tissue: influence of liposome characteristics. Biochim Biophys Acta. 1999;1421:329–339
  101. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003;2:347–360
  102. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387–6392
  103. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature, the key role of tumor selective macromolecular drug targeting. Adv Enzyme Regul. 2001;41:189–207
  104. Matsumura Y. Drug delivery systems in cancer chemotherapy. In:  Chiellini E,  Sunamato J editor. Biomedical polymers and polymer therapeutics. Berlin, Heidelberg: Springer Verlag; 2001;p. 37–52
  105. Maeda H, Sawa T, Konno T. Mechanism of tumor targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release. 2001;74:47–61
  106. Yuan F, Delian M, Fukumura D, Leunig M, Berk DA, Torchilin VP. Vascular permeability in a human tumor xenograft: molecular size dependence and cut off size. Cancer Res. 1995;55:3752–3756
  107. Dvorak HF, Brown LF, Detman M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factors, microvascular hyperpermeability and angiogenesis. Am J Pathol. 1995;146:1029–1039
  108. Feng D, Nagy JA, Pyne K, Hammel C, Dvorak HF, Dvorak AM. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation. 1999;6:23–44
  109. Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82:189–212
  110. Iakaubov LZ, Torchillin VP. A novel class of a anti-tumor antibodies: nucleosome restricted antinuclear autoantibodies (ANA) from healthy aged non-auto-immune mice. Oncol Res. 1997;9:439–446
  111. Torchillin VP, Iakaubov LZ, Estrov Z. Therapeutic potential of antinuclear autoantibodies in cancer. Cancer Ther. 2003;1:179–190
  112. Torchilin VP. Polymeric immunomicelles: carriers of choice for targeted delivery of water insoluble pharmaceuticals. J Drug Deliv Technol. 2004;4:251–261
  113. Torchillin VP, Levchenko TS, Lukyanov AN, Khaw BA, Klibanov AL, Rammohan R, et al. p-Nitrophenylcarbonyl-PEG-PE liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-Nitrophenylcarbonyl groups. Biochim Biophys Acta. 2001;1511:397–411
  114. Torchillin VP, Lukyanov AN, Gao Z, Papahadiopoulos-Stembarg B. Immunomicelles: targeted pharmaceuticals carriers for poorly soluble drugs. Proc Natl Acad Sci U S A. 2001;100:6039–6044
  115. Gao Z, Lukyanov AN, Chakilam AR, Torchillin VP. PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J Drug Target. 2003;11:87–92
  116. Gao Z, Lukyanov AN, Singhal A, Torchillin VP. Diacyl-polymer micelles as nanocarriers for poorly water soluble anticancer drugs. Nano Lett. 2002;2:979–982
  117. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchillin VP, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A. 1998;95:4607–4612
  118. Torchilin VP. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. Adv Drug Del Rev. 2005;57:95–109
  119. Campbell IG, Jones TA, Foulkes WD, Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Cancer Res. 1991;51:5329–5338
  120. Weitman SD, Lark RH, Coney LR, Fort DW, Fransca V, Zurawski VR, et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 1992;52:3396–3401
  121. Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A. Nuclear delivery of doxorubicin via folate targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res. 2000;6:1949–1957
  122. Gabizon A, Horowitz AT, Goren D, Tzemach D, Mandelbaum-Shavit F, Qazen MM, et al. Targeting folate receptor with folate linked to extremities of the poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug Chem. 1999;10:289–298
  123. Dharap SS, Qiu B, Williams GC, Sinko D, Stein S, Minko T. Molecular targeting of drug delivery systems to ovarian cancers by BH3 and LHRH peptides. J Control Release. 2003;91:61–73
  124. Zeng F, Lee H, Allen C. Epidermal growth factor conjugated poly(ethylene glycol)-block-poly(δ-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. Bioconjug Chem. 2006;17:399–409
  125. Kabanov AV, Alakhow VY. Micelles of amphiphilic block copolymers as vehicles for drug delivery. In:  Alexandris P,  Lindman B editor. Amphiphilic block copolymers: self assembly and applications. The Netherlands: Elsevier; 1997;p. 1–31
  126. Ojugo ASE, Mcsheehy PMJ, Mcintyre DJO, Mccoy C, Stubbs M, Leach MO, et al. Measurement of the extracellular pH of solid tumors in mice by magnetic resonance spectroscopy: a comparison of exogenous 19F and 31P probes NMR. Biomedicine. 1999;12:495–504
  127. Sluis RV, Bhujawalla ZM, Raghunand N, Ballesteros P, Alvarez J, Cerdan S, et al. In vivo imaging of extracellular pH using 1H MRSI. Magn Reson Med. 1999;41:743–750
  128. Patchornik A, Berger A, Katchalski E. Poly-l-histidine. J Am Chem Soc. 1957;79:5227–5230
  129. Gillies ER, Frechut JM. Development of acid sensitive copolymer micelle for drug delivery. Pure Appl Chem. 2004;76:1295–1307
  130. Sershen SR, Westcott SL, Halas NJ, West JL. Temperature-sensitive polymer nanoshell composites for photothermally modulated drug delivery. J Biomed Mater Res. 2000;51:293–296
  131. Kato N, Oishi A, Takahashi F. Enzyme reaction controlled by magnetic heating due to the hysteresis loss of γ-FeO in thermosensitive polymer gels immobilized β-galactosidase. Mater Sci Eng C. 1998;6:291–296
  132. Rapoport N, Marin A, Christensen D. Ultrasound activated micellar drug delivery. Drug Deliv Syst Sci. 2002;2:37–46
  133. Marin A, Sun H, Husseini G, Pitt W, Christensen D, Rapoport N. Drug delivery in Pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. J Control Release. 2002;84:39–47
  134. Rapoport N, Marin A, Muniruzzaman M, Christensen D. Controlled drug delivery to drug-sensitive and multidrug resistant cells: effects of Pluronic micelles and ultrasound. In:  Dinh SM editors. Advances in controlled drug delivery. 2003;p. 85–101Washington, DC
  135. Rapaport N, Marin A, Muniruzzaman M, Christensen D. Controlled drug delivery to drug-sensitive and multidrug resistant cells: effects of Pluronic micelles and ultrasound. In:  Dinh SM,  Liu P editor. Advances in controlled drug delivery: Science, Technology and Products. Volume 876:Washington, DC: American Chemical Society; 2003;p. 85–101
  136. Husseini GA, Myrup GD, Pitt WG, Christensen DA, Rapaport NY. Factors affecting acoustically triggered release of drug from polymeric micelles. J Control Release. 2000;69:43–52
  137. Rapaport N, Marin AP, Timoshin AA. Effects of a polymeric surfactants on electron transport in HL-60 cells. Arch Biochem Biophys. 2000;384:100–108
  138. Rapaport N, Pitt WG, Sun H, Nilson JL. Drug delivery iv polymeric micelles: from in vitro to in vivo. J Control Release. 2003;91:85–95
  139. Rapoport N. Combined cancer therapy by micellar-encapsulated drug and ultrasound. Int J Pharm. 2004;277:155–162
  140. Roby A, Erdogan S, Torchilin VP. Solubilization of poorly soluble PDT agent, mesotetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. Eur J Pharm Biopharm. 2006;62:235–240
  141. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med. 2003;3:643–651
  142. Hanahan D, Folkman J. Pattern and emerging mechanisms of the angiogenic switch during tumorgenesis. Cell. 1996;86:353–364
  143. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med. 1999;5:1359–1364
  144. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249–257
  145. Balasubramanian L, Evens AM. Targeting angiogenesis for the treatment of sarcoma. Curr Opin Oncol. 2006;18:354–359

 No conflict of interest was reported by the authors of this article.

PII: S1549-9634(10)00161-9

doi: 10.1016/j.nano.2010.05.005

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 6 , Pages 714-729 , December 2010

Article Tools

* Image Usage & Resolution